Profound Medical Q4 revenue $6M (+43% YoY), net loss $8.2M; installed base 78 TULSA-PRO

Profound Medical Corp.

Q4 revenue record $6.0M (+43% YoY); net loss $8.2M ($0.27/sh) vs $4.9M loss year ago.
FY2025 revenue $16.1M (up from $10.7M); net loss $42.6M ($1.41/sh) vs $27.8M loss.
TULSA-PRO installed base 78, pipeline 110; expects ~120 installs by end of 2026.
Dec 2025 financing: $36M US offering + $6.45M Canadian private placement; cash $59.7M.
Board change: Kris Shah resigns, Frank Baylis appointed; Baylis co-founded Baylis Medical (sold for $1.75B).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.